Back
Sarepta Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
32
SRPT
Sarepta Therapeutics
Last Price:
$14.08
Seasonality Move:
29.39%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
Sarepta Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.56 | Sell |
| 20-day SMA: | 18.29 | Sell |
| 50-day SMA: | 29.07 | Sell |
| 200-day SMA: | 86.06 | Sell |
| 8-day EMA: | 16.26 | Sell |
| 20-day EMA: | 10.95 | Buy |
| 50-day EMA: | 5.61 | Buy |
| 200-day EMA: | 1.6 | Buy |
Sarepta Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.01 | Buy |
| Relative Strength Index (14 RSI): | 30.81 | Sell |
| Chaikin Money Flow: | -47284273 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.93 - 25.27) | Sell |
| Bollinger Bands (100): | (23.99 - 79.25) | Sell |
Sarepta Therapeutics Technical Analysis
| Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sarepta Therapeutics Stock
Is Sarepta Therapeutics Stock a Buy?
-
Sarepta Therapeutics share price is 14.08 while SRPT 8-day simple moving average is 18.56, which is a Sell signal.
-
The stock price of SRPT is 14.08 while Sarepta Therapeutics 20-day SMA is 18.29, which makes it a Sell.
-
Sarepta Therapeutics 50-day simple moving average is 29.07 while SRPT share price is 14.08, making it a Sell technically.
-
SRPT stock price is 14.08 and Sarepta Therapeutics 200-day simple moving average is 86.06, creating a Sell signal.
SRPT Technical Analysis vs Fundamental Analysis
Sell
32
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy or a Sell?
-
Sarepta Therapeutics stock is rated a SellThe current Sarepta Therapeutics [SRPT] share price is $14.08. The Score for SRPT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
Sarepta Therapeutics Stock Info
Market Cap:
1.4B
Price in USD:
14.08
Share Volume:
78.4M
Sarepta Therapeutics 52-Week Range
52-Week High:
150.48
52-Week Low:
12.81
Sell
32
Sarepta Therapeutics (SRPT)
is a Sell
Sarepta Therapeutics Share Price Forecast
-
What is the Sarepta Therapeutics stock price today?The Sarepta Therapeutics stock price is 14.08 USD today.
-
Will SRPT stock go up or go down?Sarepta Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Sarepta Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sarepta Therapeutics is overvalued.
Is Sarepta Therapeutics Stock a Buy?
-
Sarepta Therapeutics share price is 14.08 while SRPT 8-day exponential moving average is 16.26, which is a Sell signal.
-
The stock price of SRPT is 14.08 while Sarepta Therapeutics 20-day EMA is 10.95, which makes it a Buy.
-
Sarepta Therapeutics 50-day exponential moving average is 5.61 while SRPT share price is 14.08, making it a Buy technically.
-
SRPT stock price is 14.08 and Sarepta Therapeutics 200-day simple moving average is 1.60, creating a Buy signal.
Fundamental Analysis of Sarepta Therapeutics
Is Sarepta Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.21 per share, an increase next quarter of $1.02 per share, a decrease this year of $6.30 per share, and an increase next year of $6.46 per share.
Technical Analysis of Sarepta Therapeutics
Should I short Sarepta Therapeutics stock?
-
SRPT Moving Average Covergence Divergence (MACD) indicator is 5.01, suggesting Sarepta Therapeutics is a Buy
-
Sarepta Therapeutics Relative Strength Index (RSI) is 30.81, which suggest Sarepta Therapeutics is oversold
-
The Bollinger Bands (25) for Sarepta Therapeutics is (14.93 - 25.27), which suggest Sarepta Therapeutics is a Sell
-
The Bollinger Bands (100) for Sarepta Therapeutics is (23.99 - 79.25), which suggest Sarepta Therapeutics is a Sell
* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.